Enalaprilat (Enalapril EP Impurity C)(CAS: 76420-72-9)

Enalaprilat (CAS: 76420-72-9) must adhere to regulatory guidelines such as the Chemical Abstracts Service (CAS), REACH regulations for European manufacturers, and FDA/EPA requirements for its manufacture, distribution, and use. It is classified under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) and requires appropriate handling, storage, and labeling.

Alternatives to Enalaprilat (CAS: 76420-72-9) in synthesis include using enalaprilat itself or its precursors like enalapril, which are commonly used for the synthesis of angiotensin-converting enzyme (ACE) inhibitors. Other reagents like benzyloxycarbonyl-(β-methyl-δ-thiazol-5-yl)alanine methyl ester (CMBME) can also be considered as substitutes.

The market for Enalaprilat (CAS: 76420-72-9) is closely associated with the cardiovascular health market, particularly in the treatment of hypertension. Research trends are shifting towards understanding its mechanisms and exploring potential new applications in other areas of drug development. Market trends show a steady demand driven by its role in managing arterial hypertension.

Waste containing Enalaprilat (CAS: 76420-72-9) should be collected in appropriate containers and handled according to local and international hazardous waste regulations. Incineration is a common method, but professional waste disposal services should be utilized to ensure compliance. Environmental protection measures should include proper ventilation and adherence to safety guidelines to prevent contamination and ensure worker safety.